Our Products
We offer a complete product range of RABIES VETERINARY VACCINE, (INACTIVATED) CELL CULTURE, I.P., SHEEP POX VACCINE, Typhoid Vaccine, FOWL POX VACCINE, LIVE, I. P. and Avian Infectious Bronchitis Vaccine, I.P.
tHIS VACCINE IS MANUFACTURED BY GROWING sHEEP pOX vIRUS IN lAMB tESTES cELLS. THE VACCINE CONTAINS ATTENUATED VIRUS IN FREEZE DRIED FORM.
MENINGOCOCCAL POLYSACCHARIDE VACCINE (Group A, C, Y & W135) I.P. Quadri MeningoTM
Polysaccharide vaccine against cerebrospinal meningitis caused by Neisseria meningitides Group A, C, Y &W135. Quadri MeningoTM fulfils the specification of Meningococcal Polysaccharide Vaccine as given in Indian Pharmacopoeia. The manufacturing facilities meets the requirements of cGMP guidelines of revised schedule ‘M’ of Government of India.
INDICATIONS
Prevention of cerebrospinal meningitis caused by Neisseria meningitides Group A, C, Y & W135. Vaccination is recommended in regions of endemic infection, travellers to countries with epidemic meningococcal disease (Haji pilgrims), household or institutional contacts, military recruits. It is also recommended for subjects living in closed communities and close contact of patients/carriers of Meningococcal Group A, C, Y & W135.
COMPOSITION
Each dose (0.5 ml) of vaccine contains:
Purified Polysaccharide of Neisseria meningitidis
-Group A……………………………………………………………………………………………50 µg
-Group C……………………………………………………………………………………………50 µg
-Group Y……………………………………………………………………………………………50 µg
-Group W135……………….…………………………….……………………………………50 µg
Lactose I.P. (Stabilizer) ………………………….……………………………….…5 mg
Thimerosal I.P. (Preservative) ……….………………………………………….……0.05 mg
PACK SIZE
One, five and ten dose in glass vial with appropriate diluents.
BOTULINUM TOXIN TYPE A FOR INJECTION Ph. Eur.
PURIFIED NEUROTOXIN COMPLEX
BOTO GENIE®
BOTO GENIE® (Botulinum toxin Type A) is produced from fermentation of Clostridium botulinum type A and purification of purified neurotoxin complex. It has unique pharmacological properties as a neuromuscular blocking agent by inhibiting the release of acetylcholine resulting in partial, local, flaccid muscle paralysis, which helps to reduce some of the abnormal muscle contractions. The action of BOTO GENIE® is reversible and can sustain partial chemical denervation for 3 to 6 months. Recovery of impulse transmission occurs gradually as new nerve terminals develop. One unit is defined as the median lethal intraperitoneal dose in mice estimated relative to the reference preparation assayed in parallel. The units of BOTO GENIE® are product specific and not applicable to other preparations, due to specific testing method such as vehicle dilution scheme, laboratory protocols and difference in species sensitivities. The specific activity of BOTO GENIE® is approximately 20 units/nanogram of purified neurotoxin complex.
COMPOSITION
(A) BOTO GENIE® 100 unit vial (Freeze dried)
• Botulinum toxin type A.100 unit
Purified Neurotoxin complex
• Lactose (Stabilizer).5 mg
(B) BOTO GENIE® 50 unit vial (Freeze dried)
• Botulinum toxin type A.50 unit
Purified Neurotoxin complex
· Lactose (Stabilizer).5 mg
(C) Diluent
• Sodium chloride injection I.P.
MENINGOCOCCAL POLYSACCHARIDE A & C VACCINE I.P.
Bi MeningoTM
Polysaccharide vaccine against cerebrospinal meningitis and other diseases caused by Neisseria meningitidis (Group A & C). Bi- MeningoTM fulfills the requirements of Meningococcal Polysaccharide Vaccine as given in Indian Pharmacopoeia. The manufacturing facilities meets the requirements of cGMP guidelines of revised schedule`M’ Government of India.
INDICATIONS
Prevention of cerebrospinal meningitis caused by Neisseria meningitidis (Group A & C). Vaccination is recommended in regions of endemic infection, travelers to countries with epidemic meningococcal disease, household or institutional contacts, military recruits.It is also recommended for subjects living in closed communities and close contacts of patients/carriers of Meningococcal Group A & C.
COMPOSITION
Each dose (0.5 ml) of vaccine contains:
Purified Polysaccharide of Neisseria meningitidis
Group A.50µg
Group C. 50µg
Lactose I.P. (Stabilizer). 5 mg
Thimerosal I.P. (Preservative).0.05 mg
PACK SIZE
One, five and ten doses in glass vials with appropriate diluents and disposable syringe
A clear solution containing purified Vi capsular polysaccharide of Salmonella typhi (strain Ty2) for prevention of typhoid fever. Bio TyphTM is manufactured as per Indian Pharmacopoeia. The manufacturing facilities meet the requirements as per cGMP guidelines of revised schedule ‘M’ from the Drugs & Cosmetic Act, Government of India and W.H.O. G.M.P. guidelines. Vaccine is also known by international name as Vi polysaccharide typhoid vaccine. The vaccine also confirms to W.H.O. requirement for biological substances (W.H.O. T.R.S. No. 840, 1994).
COMPOSITION : One dose (0.5 ml) contains :
PRESENTATION : One, five, ten and twenty dose in glass vials.
Bio-Med manufactures and markets its Haemophilus Type b Conjugate Vaccine under the brand name Peda Hib™. The Vaccine confirms to Indian Pharmacopoeia. Peda Hib was launched in 2004 in India (the first Indian hib vaccine).
Peda HibTM - Haemophilus type b conjugate vaccine consisting of polysaccharide (PRP) of Haemophilus type b conjugated to Tetanus toxoid protein. This stimulates T-Cell dependent antibody synthesis in infants and young children with a booster response primarily of IgG class of antibodies. Peda HibTM is manufactured as per Indian Pharmacopoeia. The manufacturing facilities meet the requirements as per cGMP guidelines of revised schedule `M’ from the Drugs and Cosmetic Act, Government of India.
COMPOSITION : Each single dose lyophilisate contains:
PACK SIZE : One, Five & Ten doses in glass vials with appropriate diluents.
This Vaccine is a formalin Inactivated Toxoid & Bacterin of Cl. perfringens. This vaccine is used for providing protection against Enteroxaemia in Sheep and Goats. It is also recommended for Cattle & Pigs.
PRESENTATION: 50 dose vial.
Additional Information:
Payment Terms :
Packaging Details : PP Vial
Delivery Time : Subject to stock, Approx 8 weeks for large supply orders
Rabies Veterinary Vaccine, I.P. VetInactivated (Cell Culture)Rabies Vet™" Rabies is a fatal neurological disease of canines specially dogs, wolves, jackals, mongoose, etc. It is caused by Rabies virus. Rabies is transmitted by bites of rabid dogs and other canines to all domesticated animals and man which in most cases results in deaths if not treated. Rabies Vet™, is prepared by inactivating Rabies virus (Pitman Moore strain) grown in VERO cell culture, with ß-propiolactone. The vaccine is available in liquid form adjuvanted with aluminium hydroxide gel. Rabies Vet™, meets Standards for rabies vaccine as per Indian Pharmacopoeia.The manufacturing facilities meet the requirements of cGMP guidelines of revised schedule `M’ of Government of India. IndicationOne ml dose of vaccine is recommended for the prevention of rabies in all types of animals, regardless of species, age and size of animals. Annual booster dose is recommended in endemic areas.
Presentation : 1 ml, 5 ml & 10 ml vials For Cattle Haemorrhagic Septicaemia (H.S.) & Black Quarter Vaccine (B.Q) are very serious disease caused by Pasteurella multocida & Clostridium Chovoei respectively. These diseases cause high mortality in unprotected cattle & sheep.
Additional Information:
Payment Terms :
Packaging Details : 25 doses in PP vial
Delivery Time : As per stocks
Attenuated, freeze dried DESCRIPTION : Ranikhet disease LaSota Strain is a Lentogenic strain. It is slightly more invassive than 'F' Strain. It is quite safe to 1-7 days old tender chicks including layers. It confers quite good immunity lasting for about 6 weeks. The vaccine contains 106 EID50 units of Ranikhet disease LaSota Strain virus per dose propogated in SPF eggs. VACCINATION SCHEDULE : Primary : Chicks should be vaccinated at 1-3 weeks age. Booster : As per advice of doctor. ADMINISTRATION : Reconstitute 200 doses in 8 ml, 500 doses in 20 ml, 1000 doses in 40 ml, 2000 doses in 80 ml and 5000 doses in 200 ml diluent. Give 1 drop orally or in nostril or in eye or by drinking water method ( as in case of F strain ). PRESENTATION : 200, 500, 1000, 2000 and 5000 dose vials. STORAGE : Store the vaccine at 20- 80C. Cool the diluent in ice one hour before start of vaccination. Always keep the reconstituted vaccine on ice during vaccination and use it within 2 hours.
Additional Information:
Payment Terms :
Packaging Details : 200, 500, 1000 dose vials
Delivery Time : Depends
This vaccine is manufactured by growing sheep pox virus in Lamb testes cells. This vaccine contains attenuated virus in freeze dried form. The vaccine has been found to cause minimal reaction at the site of injection and mild systemic reaction. The immunity conferred by this vaccine is solid (around 95%) lasting over one year.
PRESNTATION: 50 dose vial.
Poliomyelitis Vaccine, Live (ORAL) I.P. DI-VALENT (bivalent/b-OPV) (Type 1 and Type 3) :The Live Oral Polio Vaccine is a Di-valent (bivalent/b-OPV) vaccine containing mixture of type 1 and type 3 attenuated poliomyelitis viruses (Sabin strains) propagated in primary monkey kidney cells. Each dose contains an estimated mean virus titre of not less than 106.0 CCID50 for type 1, 105.8 CCID50 for type 3. 1M Mgcl2 is used as a stabilizer, Kanamycin 20 mcg per dose is added as preservative. Oral Polio vaccine is a clear liquid which have a faint yellowish to reddish colour. The colour is due to presence of phenol red indicator. The vaccine tends to shift towards yellowish colour at lower temperatures & frozen state, however this does not affect the quality of vaccine. Oral Polio Vaccine bulk used in manufacture is imported from W.H.O. prequalified supplier. Di-valent (bivalent/b-OPV) (Type 1 and Type 3) is indicated for active immunization against Type 1 and Type 3 Polio viruses.
Oral Polio Vaccine is a serious but preventable disease In India. and Hundreds thousands of infants & children used to get infected with polio virus and suffer from its serious consequences mainly paralysis.
Presentation